Consort Medical PLC Director/PDMR Shareholding (7284Y)
10 9월 2015 - 11:08PM
UK Regulatory
TIDMCSRT
RNS Number : 7284Y
Consort Medical PLC
10 September 2015
10 September 2015
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected
Persons
DTR 3.1.4
On 10 September 2015 pursuant to the rules of the Consort
Medical plc Deferred Bonus Plan 2010, the following
Directors/persons discharging managerial responsibilities ("PDMRs")
of Consort Medical plc (the "Company"), were granted immediately
exercisable awards over ordinary shares at a share price of
GBP9.6183 in the Company ("Shares").
Deferred Bonus Share Award
Director/PDMR Number of Shares
Jon Glenn 6,880
-----------------
Lisa King 2,341
-----------------
Keyvan Djamarani 1,959
-----------------
Each of the awards was granted as a nil cost option.
The awards were made following the approval given at the Annual
General Meeting held on 3 September 2015 for an adjustment in
respect of the vested and exercised 2011 Long Term Incentive Plan
and 2011 Deferred Bonus Plan awards. The adjustments are designed
to ensure that participants are unaffected by the impact of the
rights issue undertaken in 2014.
Enquiries: I Ward 01442 867920
Consort Medical plc is a leading, global, single source drug and
delivery device CDMO through its two operating subsidiaries Bespak
and Aesica. Consort Medical is at the leading edge of innovation
and is committed to investing in patient, clinician and customer
driven innovation to create new treatments, new markets and new
opportunities.
Bespak is a global market leader in the manufacture of drug
delivery devices for pharmaceutical partner companies, including
respiratory, nasal, and injectables products, and the manufacture
of devices for the point of care diagnostics market.
Aesica is a leading provider of finished dose and active
pharmaceutical ingredient (API) development and manufacturing
services to pharmaceutical partners.
The Group has facilities in King's Lynn, Cambridge, Nelson,
Milton Keynes, Cramlington, Nottingham, Queenborough and Hemel
Hempstead, UK; in Monheim and Zwickau, Germany; and in Pianezza,
Italy. Consort Medical is a public company quoted on the premium
list of the London Stock Exchange (LSE: CSRT). The Group's website
address is www.consortmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSZBLFFEKFBBBQ
(END) Dow Jones Newswires
September 10, 2015 10:08 ET (14:08 GMT)
Bespak (LSE:BPK)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Bespak (LSE:BPK)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
